Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 112 clinical trials
A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

The sponsor is planning to conduct a Phase 1, randomized, double-blind, placebo-controlled, oral single and multiple ascending-doses, parallel group study to evaluate the safety, tolerability and PK of INS018_055 in healthy subjects. The study will be conducted in 1 clinical site in the New Zealand, consisting of 2 parts: Part …

tubal ligation
hysterectomy
vasectomy
follicle stimulating hormone
body mass index
  • 0 views
  • 14 Apr, 2022
IPF mHealth Exercise

Patients with idiopathic pulmonary fibrosis (IPF) who are stable on antifibrotic therapy at least 3 months will be randomized to complete a 12-week home exercise intervention using an mHealth

nintedanib
a 12
idiopathic pulmonary fibrosis
carbon monoxide
diffusion capacity of the lung for carbon monoxide
  • 0 views
  • 18 Oct, 2021
  • 1 location
Phase ll Study of HEC585 in Patients With IPF

A Phase ll Study to evaluate the efficacy and safety of various doses of HEC585 Tablets in patients with idiopathic pulmonary fibrosis

idiopathic pulmonary fibrosis
diffusion capacity of the lung for carbon monoxide
pirfenidone
  • 0 views
  • 08 Oct, 2021
  • 1 location
Tolerability Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis IPF

This study was divided into two parts. The first part was a dose escalation study: a open label dose escalation design was used to evaluate the safety, tolerance and pharmacokinetic characteristics of ZSP1603 in IPF patients. The second part was a randomized double-blind placebo-controlled design was used to preliminatively investigate …

idiopathic pulmonary fibrosis
diffusion capacity of the lung for carbon monoxide
  • 0 views
  • 24 Nov, 2021
  • 1 location
Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy Participants

This is a phase I, First-in-Human study in healthy participants, performed at a single study center, consisting of 2 parts: Part 1 is a single ascending dose (SAD) study and Part 2 is a multiple ascending dose (MAD) study.

Accepts healthy volunteers
  • 1 views
  • 18 Apr, 2022
  • 1 location
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

IPF is a progressive scarring lung condition causing coughing and breathlessness. IPF patients often have reflux disease meaning stomach acid may be breathed into the lungs, potentially damaging them. Medicines which stop stomach acid production, proton pump inhibitors (PPIs), can be used to reduce reflux symptoms including heartburn. Some researchers …

scarring
idiopathic pulmonary fibrosis
  • 0 views
  • 22 Jul, 2021
  • 1 location
A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

This is a Phase 2, randomized, placebo controlled, multi-center study in subjects with mild to moderate IPF. Eligible subjects will be randomized to receive placebo or ENV-101 as a daily oral dose for 12 consecutive weeks of treatment. Following treatment, subjects will be observed for an additional 6 weeks.

idiopathic pulmonary fibrosis
  • 0 views
  • 26 Dec, 2021
  • 3 locations
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Idiopathic pulmonary

idiopathic pulmonary fibrosis
  • 0 views
  • 23 Mar, 2022
  • 1 location
Jin-shui Huan-xian Granule in the Treatment of IPF

This study is to evaluate the efficacy and safety of Jin-shui Huan-xian granule for idiopathic pulmonary fibrosis (IPF), establish the treatment scheme, and obtain the high quality clinical

  • 2 views
  • 26 Jan, 2021
  • 1 location
Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

This trial is a multi-centre, open-label, single-arm phase 2 trial investigating the safety, efficacy and pharmacokinetics of C21 in subjects with idiopathic pulmonary fibrosis.

emphysema
idiopathic pulmonary fibrosis
  • 0 views
  • 15 Mar, 2022
  • 14 locations